Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial - Quiz - MDSpire

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial

  • By

  • Chloe Stanley

  • Ritwika Mallik

  • Nausheen Hamid

  • Friedrich C. Jassil

  • Victoria Reuven

  • Tapiwa Ruwona

  • Samuel J. Dicken

  • Sulmaaz Qamar

  • Benjamin Norton

  • Helen Kingett

  • Andrea Pucci

  • Cormac Magee

  • David Boniface

  • Rachel L. Batterham

  • Kalpana Devalia

  • Jessica Mok

  • Mohamed Elkalaawy

  • John Loy

  • Andrew Jenkinson

  • Haris Markakis

  • Marco Adamo

  • Alanna Brown

  • Janine Makaronidis

  • May 22, 2026

  • 0 min

Share

Original Source(s)

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial

  • by Chloe Stanley, Ritwika Mallik, Nausheen Hamid, Friedrich C. Jassil, Victoria Reuven, Tapiwa Ruwona, Samuel J. Dicken, Sulmaaz Qamar, Benjamin Norton, Helen Kingett, Andrea Pucci, Cormac Magee, David Boniface, Rachel L. Batterham, Kalpana Devalia, Jessica Mok, Mohamed Elkalaawy, John Loy, Andrew Jenkinson, Haris Markakis, Marco Adamo, Alanna Brown, Janine Makaronidis

  • May 22, 2026

Related Content

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population

Birthweight, Childhood BMI: What Drives the Link?

Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.